Investors & VC Firms in Finland
125 firms in this list, with a median first check of $540K. 9 of them lead rounds. Generated from verified public data and updated continuously.
Shift4Good
ParisSeries A–Series B$540K – $21.6M
7 people
Black Pearls VC
GdanskSeed–Series A$108K – $1.1M
6 people
Evli Growth Partners
HelsinkiSeries A–Late Stage$5.4M – $10.8M
6 people
Fairpoint Capital
StockholmSeed–Series B$1.1M – $4.3M
6 people
Gorilla Capital
HelsinkiSeed–Series A$54K – $1.6M
6 people
KOMPAS VC
HørsholmSeed–Series A$1.1M – $5.4M
6 people
TEV Ventures
EssenSeed–Series B$7.6M
9 people
Zenith Venture Capital
StockholmSeed–Series B$540K – $1.1M
6 people
Debiopharm Innovation Fund
LausanneSeries A–Late Stage$3M – $5M
5 people
Nordic Foodtech VC
HelsinkiPre-Seed–Series A$540K – $2.2M
5 people
Icebreaker
HelsinkiPre-Seed–Series A$162K – $1.6M
4 people
Connect Ventures
LondonSeed–Series A$500K – $5M
4 people
GMT Communications Partners LLP
LondonGrowth$10.8M – $75.6M
4 people
Identity.vc
BerlinPre-Seed–Series A$270K – $1.6M
4 people
Kvanted
HelsinkiPre-Seed–Series A$540K – $3.2M
4 people
Nexit Ventures
HelsinkiSeed–Late Stage$540K – $10.8M
4 people
node.vc
StockholmSeed–Series A
7 people
Outlast Fund
RigaPre-Seed–Series A$270K – $1.6M
4 people
Point Nine
BerlinPre-Seed–Series A$540K – $5.4M
4 people
Sandwater
OsloSeed–Series A$4.3M
7 people
SEB Greentech Venture Capital
StockholmSeed–Series A$1.1M – $4.3M
4 people
SEB Venture Capital
StockholmSeed–Late Stage$2.2M – $10.8M
4 people
The Finnish Innovation Fund Sitra
HelsinkiSeed–Late Stage$108K
4 people
Aescap Life Sciences
AmsterdamSeed–Series A
6 people
Related lists
Seed Investors & VC Firms (7051)Series A Investors & VC Firms (4959)Crypto & Web3 Investors & VC Firms (3510)Investors & VC Firms in United States (2654)Series B Investors & VC Firms (2615)Pre-Seed Investors & VC Firms (2349)Late Stage Investors & VC Firms (2244)Seed Investors & VC Firms in United States (2211)Series A Investors & VC Firms in United States (2107)SaaS Investors & VC Firms (1994)
Data sourced from public filings and firms' own websites — see our methodology.